Loading…
Abeona Therapeutics Inc. is projected to rise to $6.55 by 2027, a +15% move from its current price of $5.69. ABEO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $5.55 | $5.69 | $5.83 | 0.00% |
| May 30 | $5.49 | $5.69 | $5.90 | 0.00% |
| May 31 | $5.45 | $5.69 | $5.94 | +0.01% |
| Jun 1 | $5.41 | $5.69 | $5.98 | +0.01% |
| Jun 2 | $5.38 | $5.69 | $6.02 | +0.01% |
| Jun 3 | $5.35 | $5.69 | $6.05 | +0.01% |
| Jun 4 | $5.33 | $5.69 | $6.08 | +0.02% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.33 | $5.69 | $6.08 | +0.02% |
| Week 2 | $5.18 | $5.69 | $6.25 | +0.03% |
| Week 3 | $5.07 | $5.69 | $6.39 | +0.05% |
| Week 4 | $4.99 | $5.69 | $6.50 | +0.06% |
| Week 5 | $4.91 | $5.69 | $6.61 | +0.08% |
| Week 6 | $4.84 | $5.70 | $6.70 | +0.09% |
| Week 7 | $4.78 | $5.70 | $6.79 | +0.11% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Abeona Therapeutics Inc. is a healthcare company that operates as a commercial-stage biopharmaceutical firm focused on developing gene and cell therapies for life-threatening diseases in the United States.
It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of Stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs.
The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
Abeona Therapeutics Inc. (ABEO) is a healthcare company with a current price of $5.44. The stock sits within a broad market of biopharma names and is tracked in the market still by a rank of 3496 with a market cap of $310.05M.
In terms of near-term trading dynamics, the 30-day range is $4.60 to $6.43, with a bullish overall sentiment. The stock’s simple moving averages run at $5.16 for the SMA50 and $5.35 for the SMA200, with near-term support at $5.06 and resistance at $6.01.
The long-range forecast outlines a path of potential upside across multiple years, with 2026 through 2050 showing rising average prices and meaningful ROI—culminating in notable upside by 2030, 2040, and 2050 as detailed in the yearly figures.
A major floor 25.7% below — a decisive break under it would weaken the trend.
The nearest floor, 10.0% below — buyers have tended to step in here.
The nearest ceiling, 5.6% above — a clean break opens room to run.
A major ceiling 14.2% above — clearing it would confirm fresh momentum.
Key ABEO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ABEO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.49 | Buy | $5.53 | Buy |
| MA 10 | $5.47 | Buy | $5.52 | Buy |
| MA 20 | $5.60 | Buy | $5.51 | Buy |
| MA 50 | $5.19 | Buy | $5.35 | Buy |
| MA 100 | $5.15 | Buy | $5.26 | Buy |
| MA 200 | $5.34 | Buy | $5.31 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.24 | Neutral |
| Stoch RSI (14) | 68.34 | Neutral |
| CCI (20) | 30.18 | Neutral |
| Williams %R (14) | -26.92 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -3.56 | Sell |
| Bollinger %B (20,2) | 0.60 | Neutral |
| Stochastic %K (14) | 73.08 | Neutral |
| TRIX (15) | 0.25 | Buy |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 53.43 | Neutral |
| Momentum (10) | 0.01 | Buy |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 5.56 | Buy |
| ADX (14) | 14.83 | Neutral |
| ATR (14) | 0.14 | Info |
The current technical picture shows a bullish sentiment. RSI14 is 50, indicating a middle-ground momentum stance, while the SMA50 sits at $5.16 and the SMA200 at $5.35.
Near term, the stock trades within a 30-day range of $4.60 to $6.43, with support at $5.06 and resistance at $6.01. This setup suggests limited downside risk near the $5 level and potential for tests of resistance near the $6 area.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.23 | $5.69 | $7.73 | 0% | Neutral | |
| $5.23 | $6.55 | $8.65 | +15% | Neutral | |
| $5.71 | $7.32 | $10.00 | +29% | Bullish | |
| $6.40 | $8.38 | $11.75 | +47% | Bullish | |
| $7.81 | $10.41 | $14.93 | +83% | Bullish | |
| $8.57 | $11.61 | $16.98 | +104% | Bullish | |
| $9.08 | $12.50 | $18.61 | +120% | Bullish | |
| $9.90 | $13.83 | $20.91 | +143% | Bullish | |
| $9.56 | $13.54 | $20.78 | +138% | Bullish | |
| $10.23 | $14.68 | $22.85 | +158% | Bullish | |
| $14.69 | $22.38 | $36.88 | +293% | Bullish | |
| $31.09 | $52.46 | $94.11 | +822% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.23 | $5.69 | $6.70 | +0.00% |
| June 2026 | $4.92 | $5.76 | $6.91 | +1.30% |
| July 2026 | $4.83 | $5.70 | $6.92 | -1.09% |
| August 2026 | $4.92 | $5.85 | $7.17 | +2.57% |
| September 2026 | $5.07 | $6.06 | $7.49 | +3.66% |
| October 2026 | $5.03 | $6.03 | $7.50 | -0.50% |
| November 2026 | $4.96 | $5.98 | $7.48 | -0.91% |
| December 2026 | $5.08 | $6.14 | $7.73 | +2.77% |
Click any year to see its month-by-month ABEO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ABEO could reach as high as $7.73, with a base case around $5.69 and support toward $4.23 — roughly 0% from $5.69. Price action looks broadly range-bound.
Expect ABEO to range from $5.23 to $8.65 through 2027. The $6.55 average target implies a +15% move from current prices. That is up +15% on the projected 2026 average. A consolidation phase looks the most probable path here.
The ABEO price prediction for 2028 points to an average of $7.32 (low $5.71, high $10.00) — a potential gain of +29% on today's $5.69. Momentum favours further upside here.
In 2029, ABEO is projected to trade between $6.40 and $11.75, averaging $8.38 — a potential gain of +47% from today's $5.69. That is up +14% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Abeona Therapeutics Inc.'s 2030 outlook centres on $10.41, within a $7.81 to $14.93 range. That is up +24% on the projected 2029 average. That marks a +83% change versus current levels. Momentum favours further upside here.
By 2031, ABEO could reach as high as $16.98, with a base case around $11.61 and support toward $8.57 — roughly +104% from $5.69. Buyers look set to stay in control over this stretch.
Expect ABEO to range from $9.08 to $18.61 through 2032. The $12.50 average target implies a +120% move from current prices. That is up +8% on the projected 2031 average. Momentum favours further upside here.
The ABEO price prediction for 2033 points to an average of $13.83 (low $9.90, high $20.91) — a potential gain of +143% on today's $5.69. Buyers look set to stay in control over this stretch.
In 2034, ABEO is projected to trade between $9.56 and $20.78, averaging $13.54 — a potential gain of +138% from today's $5.69. That is -2% versus the projected 2033 average. Momentum favours further upside here.
Abeona Therapeutics Inc.'s 2035 outlook centres on $14.68, within a $10.23 to $22.85 range. That is up +8% on the projected 2034 average. That marks a +158% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ABEO could reach as high as $36.88, with a base case around $22.38 and support toward $14.69 — roughly +293% from $5.69. Momentum favours further upside here.
Expect ABEO to range from $31.09 to $94.11 through 2050. The $52.46 average target implies a +822% move from current prices. That is up +134% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ABEO today (≈ 175.746924 ABEO) could be worth
$9,219.42
+$8,219.42 (+822%) by 2050 · US Dollar
Based on the average projected ABEO price of $52.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ABEOwould be worth at today's price.
$1,000 invested in ABEO on May 27, 2025 (≈ 163.398696 ABEO) would be worth
$929.74
-$70.26 (-7.0%) today · 0.93× · US Dollar
Based on a ABEO entry price of $6.12 vs. today's $5.69.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.32 | $1,069.55 | +7.0% |
| 1 month ago | $5.34 | $1,065.54 | +6.6% |
| 3 months ago | $5.2 | $1,094.23 | +9.4% |
| 6 months ago | $5.07 | $1,122.29 | +12.2% |
| 1 year ago | $6.12 | $929.74 | -7.0% |
| All time (5.0y) ago | $42.75 | $133.1 | -86.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ABEO forecast.
Our base-case forecast reaches $11.00 around 2031.
Implied market cap at $11.00: $626.95M
The multi-year forecast projects substantial upside, with 2030 showing an average price of $9.93 and a 82.5% ROI while remaining bullish; 2040 delivers an average of $21.46 with a 294.4% ROI and bullish sentiment; and 2050 shows an average of $50.46 with an 827.7% ROI, continuing bullish momentum.
Earlier years like 2026 show a 2026 average of $5.44 and a 2027 average of $6.23, indicating a gradual upward trajectory with positive sentiment in the near-to-intermediate term. These figures are estimates and reflect market expectations for Abeona Therapeutics Inc.; actual results may differ.
Tap a question to reveal the answer.
2030 forecast: min $7.43, avg $9.93, max $14.28 with ROI 82.5% and sentiment BULLISH.
2040 forecast: min $14.01, avg $21.46, max $35.54 with ROI 294.4% and sentiment BULLISH.
2050 forecast: min $29.68, avg $50.46, max $91.05 with ROI 827.7% and sentiment BULLISH.
Current price $5.44; market cap $310.05M; rank 3496.
Sentiment BULLISH; RSI14 50; SMA50 $5.16; SMA200 $5.35; support $5.06; resistance $6.01; 30-day range $4.60-$6.43.
Abeona Therapeutics Inc. Community Discussion
0Share your Abeona Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.